Evidence map›Paper›PMID 20709820›Full record

Trial reportAmerican journal of respiratory and critical care medicine2011

Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.

Xiangyang Kong, Michael H Cho, Wayne Anderson, Harvey O Coxson, Nestor Muller, George Washko, Eric A Hoffman, Per Bakke, Amund Gulsvik, David A Lomas and 3 more

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00292552 (A Multicentre 3 Year Longitudinal Prospective Study to Identify Novel Endpoints and Compare These With Forced Expiratory Volume in 1 Second), which is not on this map. Cited by 65 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 4 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00292552 completednot on this map

A Multicentre 3 Year Longitudinal Prospective Study to Identify Novel Endpoints and Compare These With Forced Expiratory Volume in 1 Second (FEV1) for Their Ability to Measure and Predict COPD Severity and Its Progression Over Time

TypeobservationalSponsorGlaxoSmithKlineRan2005 to 2010Enrolled2,747ConditionsPulmonary Disease, Chronic ObstructiveArmsNovel endpoint determination
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 4 syntheses or guidelines pooled it, 152 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Mendelian causes of early-onset emphysema: a review of the current literature.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  10. Article
  11. Mechanisms and markers of lung ageing in health and disease.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  12. Review
  13. Autophagy in asthma and chronic obstructive pulmonary disease.Clinical science (London, England : 1979) · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Xiangyang KongResearch and Development, GlaxoSmithKline, 709 Swedeland Road, UW2230, King of Prussia, PA 19406, USA. xiangyang.q.kong@gsk.com
Michael H Cho
Wayne Anderson
Harvey O Coxson
Nestor Muller
George Washko
Eric A Hoffman
Per Bakke
Amund Gulsvik
David A Lomas
Edwin K Silverman
Sreekumar G Pillai
ECLIPSE Study NETT Investigators
Brigham and Women's Hospital · USHaukeland University Hospital · NOResearch Triangle Park Foundation · USUniversity of British Columbia · CAGlaxoSmithKline (United Kingdom) · GBUniversity of Cambridge · GBUniversity of Iowa · US

Funding

Statistical GeneticsP01HL083069 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2007 to 2011
$12.2M
Fine Mapping of COPD Susceptibility GenesR01HL075478 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2004 to 2012
$6.4M
Genetic Determinants of COPD in Diverse Ethnic GroupsR01HL084323 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2010
$2.6M
Translational Genetics and Genomics of Airways DiseasesK12HL089990 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2007 to 2012
$1.9M
CLINICAL COORDINATING CENTER FOR LVRS-N01HR76119-268076119-268076119N01HR076119 · HR · JOHNS HOPKINS UNIVERSITY · PI PIANTADOSI, STEVEN · 1997 to 2006
$871k
APPROACHES TO IDENTIFY RARE AND COMMON GENETIC DETERMINANTS IN SEVERE COPDK08HL097029 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHO, MICHAEL H. · 2010 to 2013
$548k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076118 · HR · UNIVERSITY OF WASHINGTON · PI ALBERT, RICHARD K · 1997 to 2000
$225k
CLINICAL CENTER FOR THE LUNG VOLUME REDUCTION SURGERYN01HR076101 · HR · BAYLOR COLLEGE OF MEDICINE · PI ESPADA, RAFAEL · 1997 to 2000
$134k
CLINICAL CENTER FOR LVRSN01HR076116 · HR · TEMPLE UNIVERSITY · PI CRINER, GERALD J · 1997 to 2000
$15k
Medical Research Council G0500306NHLBI NIH HHS K08 HL097029NHLBI NIH HHS K12HL089990NHLBI NIH HHS N01HR76101NHLBI NIH HHS N01HR76116NHLBI NIH HHS N01HR76118NHLBI NIH HHS N01HR76119NHLBI NIH HHS P01HL083069NHLBI NIH HHS R01HL084323NHLBI NIH HHS R01HL75478
6 · The paper itself

Abstract

rationalechronic obstructive pulmonary disease (COPD), characterized by airflow limitation, is a disorder with high phenotypic and genetic heterogeneity. Pulmonary emphysema is a major but variable component of COPD; familial data suggest that different components of COPD, such as emphysema, may be influenced by specific genetic factors.

objectivesto identify genetic determinants of emphysema assessed through high-resolution chest computed tomography in individuals with COPD.

methodswe performed a genome-wide association study (GWAS) of emphysema determined from chest computed tomography scans with a total of 2,380 individuals with COPD in three independent cohorts of white individuals from (1) a cohort from Bergen, Norway, (2) the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study, and (3) the National Emphysema Treatment Trial (NETT). We tested single-nucleotide polymorphism associations with the presence or absence of emphysema determined by radiologist assessment in two of the three cohorts and a quantitative emphysema trait (percentage of lung voxels less than -950 Hounsfield units) in all three cohorts. MEASUREMENTS AND MAIN

resultswe identified association of a single-nucleotide polymorphism in BICD1 with the presence or absence of emphysema (P = 5.2 × 10(-7) with at least mild emphysema vs. control subjects; P = 4.8 × 10(-8) with moderate and more severe emphysema vs. control subjects).

conclusionsour study suggests that genetic variants in BICD1 are associated with qualitative emphysema in COPD. Variants in BICD1 are associated with length of telomeres, which suggests that a mechanism linked to accelerated aging may be involved in the pathogenesis of emphysema. Clinical trial registered with www.clinicaltrials.gov (NCT00292552).

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticAdaptor Proteins, Signal TransducingCytoskeletal ProteinsDNAFemaleFollow-Up StudiesGenome-Wide Association StudyGenotypeHumansIn Vitro TechniquesMaleMiddle AgedPulmonary Disease, Chronic ObstructivePulmonary EmphysemaSpirometryAdaptor Proteins, Signal TransducingBICD1 protein, humanCytoskeletal ProteinsDNA

Identifiers

PMID20709820
PMCPMC3040393
OpenAlexW2100074859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.